Pzena Investment Management LLC Has $969.10 Million Holdings in Amdocs Limited $DOX

Pzena Investment Management LLC increased its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 82.6% in the fourth quarter, Holdings Channel.com reports. The firm owned 12,037,015 shares of the technology company’s stock after purchasing an additional 5,443,766 shares during the quarter. Amdocs makes up 2.9% of Pzena Investment Management LLC’s holdings, making the stock its 10th largest holding. Pzena Investment Management LLC owned approximately 0.11% of Amdocs worth $969,100,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. Scotia Capital Inc. increased its stake in Amdocs by 3.5% during the 3rd quarter. Scotia Capital Inc. now owns 4,289 shares of the technology company’s stock worth $352,000 after purchasing an additional 145 shares in the last quarter. CENTRAL TRUST Co increased its stake in Amdocs by 6.1% during the 3rd quarter. CENTRAL TRUST Co now owns 2,741 shares of the technology company’s stock worth $225,000 after purchasing an additional 158 shares in the last quarter. WealthCollab LLC increased its stake in Amdocs by 94.5% during the 3rd quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock worth $29,000 after purchasing an additional 173 shares in the last quarter. Rossby Financial LCC increased its stake in Amdocs by 39.3% during the 3rd quarter. Rossby Financial LCC now owns 620 shares of the technology company’s stock worth $50,000 after purchasing an additional 175 shares in the last quarter. Finally, Blair William & Co. IL increased its stake in Amdocs by 5.5% during the 3rd quarter. Blair William & Co. IL now owns 3,393 shares of the technology company’s stock worth $278,000 after purchasing an additional 177 shares in the last quarter. 92.02% of the stock is owned by institutional investors.

Amdocs Price Performance

Shares of DOX opened at $62.36 on Friday. The stock has a market capitalization of $6.73 billion, a P/E ratio of 12.47, a P/E/G ratio of 0.96 and a beta of 0.40. Amdocs Limited has a twelve month low of $59.40 and a twelve month high of $95.41. The company has a 50 day moving average of $64.73 and a 200-day moving average of $72.87. The company has a quick ratio of 1.06, a current ratio of 0.98 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last released its earnings results on Thursday, May 14th. The technology company reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.77 by $0.01. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The business had revenue of $1.17 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same period last year, the business earned $1.78 earnings per share. The firm’s revenue was up 3.9% on a year-over-year basis. As a group, equities research analysts forecast that Amdocs Limited will post 7.41 EPS for the current fiscal year.

Amdocs Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a $0.569 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.28 annualized dividend and a dividend yield of 3.6%. Amdocs’s dividend payout ratio (DPR) is currently 45.60%.

Wall Street Analysts Forecast Growth

DOX has been the subject of several research reports. Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. Stifel Nicolaus decreased their price target on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating for the company in a research note on Thursday, May 14th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Amdocs in a research note on Friday, May 8th. Cfra cut shares of Amdocs to a “sell” rating in a research note on Thursday, May 14th. Finally, Barclays decreased their price target on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday, February 4th. Three analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $86.67.

Amdocs Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.